You may have heard about the “three-parent” technique and wonder if it can be used in a surrogacy process. Although it sounds very futuristic, it is a technique that already exists and has generated a lot of interest due to its potential to prevent hereditary diseases.
The technique known as mitochondrial transfer or “three-parent” is an advanced method of assisted reproduction that uses genetic material from three different people: the nuclear DNA of the mother and father, and the mitochondrial DNA of a donor.
This technique was originally designed to prevent serious genetic diseases that are passed on through the mother’s mitochondria.
This process involves:
Currently, this technique is not commonly used in surrogacy processes, although it can be used and Gestlife has a special program in Albania with this technique at . Its use is highly regulated and restricted due to the ethical, legal, and medical concerns involved. Only a few countries, such as the United Kingdom, have passed specific legislation for its limited use and exclusively to prevent serious mitochondrial diseases.
Specialized companies such as GestLife include this technique in their standard programs.
It would only be considered in specific medical situations, particularly when there is a significant risk of transmission of serious mitochondrial diseases from mother to child, and in countries where its use is clearly permitted and regulated.
The three-parent technique raises important ethical debates because it involves genetic manipulation of the embryo. The most common concerns include:
For these reasons, its use is strictly limited to specific medical cases and is highly regulated.
Currently, the United Kingdom is one of the few countries that has explicitly authorized this technique under strict regulations and medical controls. Other countries are still engaged in legal and ethical debates on the matter and do not allow it. However, these techniques are practiced in other countries such as Albania and Ukraine, where there is no legislation regulating or prohibiting them.
If you are interested in surrogacy and preventing genetic diseases, there are other widely used and safe alternatives, such as:
These alternatives are available through agencies such as GestLife, which advise prospective parents on the best procedure for their medical and personal needs.
Although the three-parent technique exists, its use in surrogacy is currently very limited and regulated. For most cases, other more accessible and safer options are preferable.
– Is it common to use the three-parent technique in surrogacy?
No, it is not common due to ethical, legal, and medical restrictions.
– What is the main objective of this technique?
To prevent the transmission of serious mitochondrial diseases.
– In which countries is this technique permitted?
Mainly in the United Kingdom under strict regulation, although it is also permitted in Albania and Ukraine.
– What alternatives are there to prevent genetic diseases?
Preimplantation genetic selection and the use of genetically healthy donors.
– Are there any risks associated with this technique?
Yes, there are ethical and potentially unknown long-term risks.